Moderna (NASDAQ:MRNA) has hands-down delivered the best stock performance among leading COVID-19 vaccine makers over the last 12 months. The biotech’s shares have skyrocketed nearly sixfold during …
https://www.fool.com/investing/2021/08/29/why-novavax-stock-will-beat-moderna-over-next-year/